GIGA-Cyclotron Research Centre-In Vivo Imaging and.
Psychology and Cognitive Neuroscience Research Unit, University of Liège (ULiège), Liège, Belgium.
JCI Insight. 2021 Jan 25;6(2):142514. doi: 10.1172/jci.insight.142514.
BACKGROUNDNeuronal hyperexcitability characterizes the early stages of Alzheimer's disease (AD). In animals, early misfolded tau and amyloid-β (Aβ) protein accumulation - both central to AD neuropathology - promote cortical excitability and neuronal network dysfunction. In healthy humans, misfolded tau and Aβ aggregates are first detected, respectively, in the brainstem and frontomedial and temporobasal cortices, decades prior to the onset of AD cognitive symptoms. Whether cortical excitability is related to early brainstem tau - and its associated neuroinflammation - and cortical Aβ aggregations remains unknown.METHODSWe probed frontal cortex excitability, using transcranial magnetic stimulation combined with electroencephalography, in a sample of 64 healthy late-middle-aged individuals (50-69 years; 45 women and 19 men). We assessed whole-brain [18F]THK5351 PET uptake as a proxy measure of tau/neuroinflammation, and we assessed whole-brain Aβ burden with [18F]Flutemetamol or [18F]Florbetapir radiotracers.RESULTSWe found that higher [18F]THK5351 uptake in a brainstem monoaminergic compartment was associated with increased cortical excitability (r = 0.29, P = 0.02). By contrast, [18F]THK5351 PET signal in the hippocampal formation, although strongly correlated with brainstem signal in whole-brain voxel-based quantification analyses (P value corrected for family-wise error [PFWE-corrected] < 0.001), was not significantly associated with cortical excitability (r = 0.14, P = 0.25). Importantly, no significant association was found between early Aβ cortical deposits and cortical excitability (r = -0.20, P = 0.11).CONCLUSIONThese findings reveal potential brain substrates for increased cortical excitability in preclinical AD and may constitute functional in vivo correlates of early brainstem tau accumulation and neuroinflammation in humans.TRIAL REGISTRATIONEudraCT 2016-001436-35.FUNDINGF.R.S.-FNRS Belgium, Wallonie-Bruxelles International, ULiège, Fondation Simone et Pierre Clerdent, European Regional Development Fund.
神经元兴奋性过高是阿尔茨海默病(AD)早期的特征。在动物模型中,早期错误折叠的 tau 和淀粉样β(Aβ)蛋白的积累——这两者都是 AD 神经病理学的核心——促进了皮质兴奋性和神经元网络功能障碍。在健康的人类中,分别在脑干和额内侧和颞底皮质中最早检测到错误折叠的 tau 和 Aβ 聚集物,这比 AD 认知症状的发生早几十年。皮质兴奋性是否与早期脑干 tau 及其相关的神经炎症以及皮质 Aβ 聚集物有关尚不清楚。
我们使用经颅磁刺激结合脑电图技术,对 64 名健康中老年个体(50-69 岁;45 名女性和 19 名男性)的额叶皮质兴奋性进行了探测。我们评估了全脑[18F]THK5351 PET 摄取作为 tau/神经炎症的替代指标,并且我们使用[18F]Flutemetamol 或[18F]Florbetapir 放射性示踪剂评估了全脑 Aβ 负担。
我们发现,单胺能脑干部位[18F]THK5351 摄取增加与皮质兴奋性增加相关(r = 0.29,P = 0.02)。相比之下,虽然[18F]THK5351 PET 信号在海马结构中与全脑基于体素的定量分析中的脑干部位信号强烈相关(针对组间错误进行校正的 P 值[PFWE-corrected] < 0.001),但与皮质兴奋性无显著相关性(r = 0.14,P = 0.25)。重要的是,皮质早期 Aβ 沉积与皮质兴奋性之间未发现显著相关性(r = -0.20,P = 0.11)。
这些发现揭示了 AD 临床前阶段皮质兴奋性增加的潜在脑基础,并且可能构成人类早期脑干部位 tau 积累和神经炎症的功能性体内相关性。
EudraCT 2016-001436-35。
F.R.S.-FNRS 比利时、瓦隆-布鲁塞尔国际、列日大学、Simone 和 Pierre Clerdent 基金会、欧洲区域发展基金。